Understanding how a specific enzyme helps protect cells from damage
The Biology of Peroxiredoxin 6
This study is looking at an important enzyme called Prdx6 that helps protect our cells from damage, especially in conditions like lung injuries, diabetes, and brain diseases, to find new ways to prevent or treat these health problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11140844 on NIH RePORTER |
What this research studies
This research investigates the enzyme Peroxiredoxin 6 (Prdx6), which plays a crucial role in protecting cells from oxidative damage by repairing cell membranes. The study focuses on how Prdx6 functions in various conditions, including acute lung injury and chronic diseases like diabetes and neurodegenerative disorders. By examining the enzyme's activities and its role in regulating a type of cell death called ferroptosis, the research aims to uncover new therapeutic targets for these serious health issues. Patients may benefit from insights gained about how to prevent or treat conditions related to oxidative stress and cell damage.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from acute lung injury, type 2 diabetes, or chronic central nervous system diseases.
Not a fit: Patients with conditions unrelated to oxidative stress or cell membrane damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for conditions like lung injury, diabetes, and neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results in understanding the role of similar enzymes in cell protection, suggesting potential for success in this area.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Vazquez Medina, Jose P — University of California Berkeley
- Study coordinator: Vazquez Medina, Jose P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.